[1]
Sakalo, A., Sakalo, V., Khimich, I., Kuranov, Y., Diatel, M., Navrotskyi, B. and Valchishin, A. 2022. Hypogonadism as a Risk Factor for Metabolic Syndrome and Vascular Diseases in Patients with Germ Cell Tumors of the Testis After Treatment. Health of Man. 1-2 (Jun. 2022), 22–26. DOI:https://doi.org/10.30841/2307-5090.1-2.2022.263900.